Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06137404

A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger

The purpose of this research is to evaluate the effectiveness of two splint designs in conservative management of trigger finger.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Trigger Finger Muscular Diseases Musculoskeletal Diseases Tendinopathy Tendon Entrapment Trigger Finger Disorder

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Waikato Hospital

Hamilton, Waikato Region, 3204, New Zealand

About this study

This study aims to analyse and compare the effectiveness of metacarpophalangeal joint blocking splint versus relative motion extension splint for trigger finger. This will help us find out which one of the two splint designs is more effective in the management of trigger finger, thus improving treatment outcomes for patients with trigger finger.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Trigger finger patient

Exclusion criteria

  • Diabetes, non-English speaking

Treatment and study plan

splint

Other

Comparison of splints for trigger finger

Primary outcomes

  1. Green's classification for trigger finger

    Time frame: 12 weeks

    Green's classification is an objective outcome measure. The therapist grades the triggering by observing the finger when the patient makes a full fist.

    Grade I: Pain/history of catching Grade II: Demonstrable catching but can actively extend digit Grade III: Demonstrable locking, requiring passive extension Grade IV: Fixed flexion contracture

    Lowest score is I; highest score is IV

Secondary outcomes

  1. QuickDASH (Disability of Arm, Shoulder and Hand)

    Time frame: 12 weeks

    The QuickDASH is a patient rated questionnaire that rates patient's ability to perform certain tasks as well as severity of symptoms. The best score is 0 (no difficulty) and the lowest score is 100 (severe difficulty).

Other outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: 12 weeks

    The VAS is a patient rated outcome measure that enables the patient to rate the intensity of pain from 0 (no pain) to 10 (worse pain that can possibly be)

Sponsors and collaborators

Lead sponsor

Waikato Hospital

Other

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2028
First posted
Nov 18, 2023
Registry last updated
Apr 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.